Company Name: uniQure N.V.  

uniQure N.V. is engaged in gene therapy. The company’s initial focus is on the development of gene therapies designed to treat rare diseases. Additionally, the company has a strategic partnership to develop gene therapies for cardiovascular diseases with Bristol-Myers Squibb.

Ticker Symbol: QURE (NASDAQ)

Company Website: www.uniqure.com

Social Media: UniQure LinkedIn

Headquarters: Amsterdam, the Netherlands